GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » Total Long-Term Liabilities

Cipla (BOM:500087) Total Long-Term Liabilities : ₹6,138 Mil (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Cipla Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Cipla's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹6,138 Mil.

Cipla Total Long-Term Liabilities Historical Data

The historical data trend for Cipla's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Total Long-Term Liabilities Chart

Cipla Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,747.50 10,705.30 6,400.70 6,697.20 6,138.30

Cipla Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,697.20 - 7,447.00 - 6,138.30

Cipla Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Cipla Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cipla's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » Total Long-Term Liabilities
Comparable Companies
NSE:TORNTPHARM BOM:500124 BOM:543904 BOM:532321 BOM:500257 NSE:AUROPHARMA NSE:DIVISLAB BOM:500488 NSE:ALKEM BOM:543064 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ HKSE:03692 XTAE:TEVA SHSE:688506
Traded in Other Exchanges
CIPLA:India
Address
Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Website
https://www.cipla.com
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines